Piperazine

Piperazine

SCHEMBL11068926

C1CNCCN1.CCCCC(CC)C(=O)OCCO

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.53
CA1 P00915 4/20 0.53
MAPK1 P28482 1/20 0.44
ACHE P22303 1/20 0.39
GAA P10253 1/20 0.36
XBP1 P17861 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL394474 0.90 CA2 (0.63) CA2CA1MAPK1ACHEGAA
SCHEMBL609048 0.84 CA2 (0.53) CA2CA1MAPK1ACHEGAA
Ethylene Glycol SCHEMBL9625020 0.83 CA2 (0.63) CA2CA1MAPK1ACHEGAA
SCHEMBL1428342 0.83 CA2 (0.52) CA2CA1MAPK1ACHEATM
SCHEMBL9327517 0.82 CA2 (0.61) CA2CA1MAPK1ACHEGAA
SCHEMBL154056 0.81 CA2 (0.70) CA2CA1MAPK1ACHEGAA
SCHEMBL8985885 0.81 CA2 (0.56) CA2CA1MAPK1ACHEGAA
SCHEMBL9167701 0.81 CA2 (0.56) CA2CA1MAPK1ACHEGAA
SCHEMBL17626978 0.81 CA2 (0.56) CA2CA1MAPK1ACHEGAA
SCHEMBL474747 0.81 CA2 (0.56) CA2CA1MAPK1ACHEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4483974-A POLYMERIZATION INHIGITION BY BLOCKING WITH AMINE, HYDRAZINE, OR HYDRAZIDE BAYER AKTIENGESELLSCHAFT (DE) 1984-11-20 US disclosed